C-NMR spectra of 3 revealed the presence of a syringin moiety, 16) (Table 1) Since compounds 1-3 were obtained at a very low yield, the usual approach to absolute configuration of the HMG moiety based on reductive hydrolysis could not be applied. 17) The absolute configuration of the HMG moiety in compounds 1-3 was not elucidated yet.
Oplopanphesides A-C (1-3) had been evaluated for their a-glucosidase inhibition activity, they were inactive (IC 50 Ͼ50 mM, respectively). In addition, the cytotoxic activities of these new glycosides against the human cancer cell lines (MDA-231 and MCF-7) were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. As a result, the activities of these compounds were inactive (IC 50 Ͼ100 mM, respectively).
Experimental
General Procedures Optical rotations were measured on a PerkinElmer Model 341 polarimeter. UV spectra were recorded on a Beckman Coulter DU 640 spectrophotometer. IR spectra were obtained with a PerkinElmer Spectrum 100 FT-IR spectrometer with KBr pallets. The C-NMR spectrometric data are given in Table 1 . HR-ESI-MS m/z: 511.1420 [MϩNa] ϩ (Calcd for C 21 H 28 O 13 Na: 511.1422). 1420, 1382, 1356, 1333, 1244, 1195, 1127, 1080, 1019, 909, 843, 702. 1 Hand 13 C-NMR spectrometric data are given in Table 1 . HR-ESI-MS m/z: 539.1741 [MϩNa] ϩ (Calcd for C 23 H 32 O 13 Na: 539.1735). Acid Hydrolysis Compounds 1 (2 mg) and 2 (2 mg) were hydrolyzed with 2 mol · l Ϫ1 TFA (1 ml) in a sealed glass tube with screw cap which were filled with N 2 at 100°C for 2 h, respectively. The hydrolyzed solution was evaporated to dryness under 50°C and then methanol (2 ml) was added for further evaporation and complete removal of trifluoroacetic acid (TFA). The hydrolysate was used for derivatization.
Sugar Analysis The stock solution of standard monosaccharides (1 ml) was treated with hydroxylamine hydrochloride-pyridine solution (1 ml) in a sealed glass tube at 90°C for 30 min. Acetic anhydride (1 ml) was added and continuing heated for another 30 min after the solution cooling to room temperature. The cooled solution was evaporated to dryness under diminished pressure at 50°C. The residue was dissolved in dry methanol (2 ml) was added. The mixture was filtered through 0.45 mm syringe filter (Agilent Technologies) prior to injection into GC-MS system. The hydrolysate was reacted with hydroxylamine hydrochloride and acetic anhydride to form the derivatives directly as in the procedures mentioned above for sugar determination. GC-MS was performed on an Agilent 6890 gas chromatography instrument coupled with an Agilent 5973 mass spectrometer (Agilent Technologies, Palo Alto, CA, U.S.A.). A HP-5MS capillary column (30 mϫ 0.25 mm, i.d.) coated with 0.25 mm film 5% phenyl methyl siloxane was used for separation. The column temperature was set at 175°C and held for 7 min, then programmed at 5°C · min Ϫ1 to 185°C and held for 5 min, then at 4°C · min Ϫ1 to 230°C. Split injection (2 ml) with a split ratio of 1 : 50 was applied. High purity helium was used as carrier gas with flow rate of 1.0 ml · min
Ϫ1
. The mass spectrometer was operated in electron-impact (EI) mode, the scan range was 40-550 amu, the ionization energy was 70 eV and the scan rate was 2.89 s per scan. The inlet, ionization source temperature were 250 and 280°C, respectively. a a-Glucosidase Inhibition Assay The inhibitory activity of the phenolic glycosides on a-glucosidase was measured spectrophotometrically on 96-well microplate reader. The absorbance (A S ) was recorded at 405 nm. Briefly, 20 ml of 100 mM phosphate buffer (pH 6.8), 20 ml of 2.5 mM PNPG, and 20 ml of investigated compounds in the buffer were mixtured to a total of 60 ml reaction system in the wells, which was added 20 ml of 0.2 U/ml a-glucosidase in phosphate buffer and mixed well. After incubation for 15 min at 37°C, the reaction was stopped by adding 80 ml of 0.2 M sodium carbonate solution. The control sample was the mixture of the test sample with solvent instead. The sample and control blanks were the mixtures of sample and control, respectively, except a-glucosidase was instead with buffer, respectively. The inhibition (%) of test sample on a-glucosidase could be calculated as inhibition [inhibition (%)ϭ100ϫ(A S ϪA SB )/(A C ϪA CB )], where A S , A SB , A C , and A CB are the absorbance of sample, sample blank, control, and control blank, respectively. The measurement was performed in triplicates.
Cytotoxicity Assay MDA-231 (human breast cancer cell line) and MCF-7 (human breast cancer cell line) were utilized. The cells were cultured in RPMI-1640 or Dulbecco's modified Eagle's medium (DMEM) (Hyclone, Logan, UT, U.S.A.), added with 10% (v/v) fetal bovine serum (Hyclone, U.S.A.) in a humidified atmosphere with 5% CO 2 at 37°C. Cell viability was determined by recording colorimetric measurements of the amount of insoluble formazan formed in living cells based on the reduction of MTT (Sigma, St. Louis, MO, U.S.A.). In brief, before drug addition, 100 ml adherent cells were seeded into each well of a 96-well cell culture plate and allowed to adhere for 12 h, while suspended cells were seeded each with initial density of 1ϫ10 5 cells/ml in 100 ml medium. Each tumor cell line was exposed to the tested compound at various concentrations (0.1, 1.0, 10, 100 mM/l) in triplicates for 48 h, with cis-platin (Sigma, U.S.A.) as positive control. After the incubation, MTT (100 mg) was added to each well, and the incubation was stopped after 4 h at 37°C. The cells were lysed with 100 ml 20% sodium dodecyl sulfate (SDS)-50% N,N-dimethylformamide (DMF) after removal of 100 ml medium. The optical densities (A) of 570 nm were measured using a Bio-Rad 580 enzyme-linked immunosorbent assay microplate reader. The cytotoxicity was calculated as cytotoxicity (%)ϭ[(A 570 of untreated cellsϪA 570 of treated cells)/A 570 of untreated cells]ϫ100%.
